DRIVEN TO IMPROVE THE PRODUCTIVITY OF BIOPHARMA R&D_
DRIVEN TO IMPROVE THE PRODUCTIVITY OF BIOPHARMA R&D

Our Core Values

  • INTEGRITY
  • PASSION
  • RESULTS

"I am an optimist and convinced that technology can improve healthcare around the world. We have recently shown that our software is superior at estimating clinical trial probabilities. For this we have granted a license to a new firm applying our technology to the financial markets."

- Dietmar Hopp, Anchor Investor in Molecular Health (via dievini GmbH)

"We are transforming outcomes for patients, and optimising the use of resources in the healthcare ecosystem, by bringing our proprietary databases to cutting edge AI-based scientific computing."

- Friedrich von Bohlen, Founder, Molecular Health GmbH

"We want to improve patient lives and lower the cost of healthcare. We think taking Molecular Health's technology, and applying it to the financial markets, will be the quickest way to get there."

- Amit Karna, Founder, Daten Capital LLP

Our Core Values

  • INTEGRITY
  • PASSION
  • RESULTS

INTERVIEW WITH CEOs of DATEN CAPITAL AND MOLECULAR HEALTH

Video Thumbnail
Video Thumbnail
Please enter your email address to view this video.